智通财经网·2026-02-24 11:51Core Viewpoint - Morgan Stanley increased its stake in China National Pharmaceutical Group (01099) by 347,233 shares at an average price of HKD 21.4135 per share, totaling approximately HKD 7.4355 million, bringing its total holdings to about 67.1203 million shares, representing a 5% ownership [1] Summary by Category - Investment Activity - Morgan Stanley's recent purchase of 347,233 shares indicates a strategic investment move in China National Pharmaceutical Group [1] - The average purchase price of HKD 21.4135 per share reflects the current market valuation and investor confidence in the company [1] - Ownership Structure - Following the acquisition, Morgan Stanley's total shareholding in China National Pharmaceutical Group stands at approximately 67.1203 million shares [1] - The updated ownership percentage of 5% signifies a notable stake in the company, which may influence future corporate decisions and market perception [1]